E-cadherin, one of the most studied proteins with regard to epithelial-mesenchymal transition (EMT), is a member of the classic family of cadherins. This calciumdependent, transmembrane cell adhesion protein is expressed on the surface of epithelial tissues and plays important roles in epithelial cell behavior, tissue formation, and tumor suppression. 1 Cadherins form adherens junctions by interacting with other intracellular components and provide mechanical attachments between adjacent cells. Besides its role in mediating contact inhibition of proliferation, the cytoplasmic tail of E-cadherin forms a dynamic complex with catenins and regulates several intracellular signal transduction pathways, including Wingless-related integration/b-catenin, phosphoinositide 3-kinase/Protein Kinase B, Rho guanosine triphosphatase, and nuclear factor-kB signaling. 2 In the current issue of Cellular and Molecular Gastroenterology and Hepatology, Kaneta et al 3 have uncovered a previously understudied role of E-cadherin in maintaining tissue homeostasis and tumorigenesis in the pancreas. Partial or complete loss of E-cadherin in epithelial cells has been associated with their progression toward malignancy in a number of cancers. The up-regulation of the transcriptional repressors Snail Family Transcriptional Repressor 1, Zinc finger E-box-binding homeobox 1, Snail Family Transcriptional Repressor 2, and Zinc finger E-boxbinding homeobox 2, which target the E-cadherin promoter or its methylation, are the most common causes of E-cadherin expression loss in human tumors. 4 Down-regulation of E-cadherin results in less intercellular contact and reduced cell polarity, promoting EMT, cancer invasion, and metastasis. 5-7 In gastric cancer, function loss of the E-cadherin gene, CDH1, has been associated with diffuse gastric cancer susceptibility, and it is involved in the initiation and progression of both sporadic and hereditary forms of the disease. 8-10 Abnormal reduction or loss of E-cadherin expression have been observed in 42%-60% of human pancreatic cancer specimens, especially in undifferentiated, noncohesive pancreatic tumors, which was associated with a poor patient outcome. 11 However, the exact role of Ecadherin loss in EMT induction and pancreatic cancer development remains unknown. In the study by Kaneta et al, 3 they investigated the physiologic and pathologic roles of E-cadherin in a pancreas-specific conditional knockout mouse model. In the Ptf1a-Cre; Cdh1 flox/flox mice (PC mice), they observed a reduction of acinar cells with increased levels of serum amylase, inflammatory cytokines, and CD45-positive cell infiltration. This suggested a pancreatitis-like phenotype.